Home / Drug shortages / Remifentanil Hydrochloride Injection

Remifentanil Hydrochloride Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Remifentanil Hydrochloride Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 06/28/2022.

Shortage Details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0143-9393-10
Dosage Form
Injection
Presentation
Remifentanil Hydrochloride, Injection, 5 mg per vial (NDC 0143-9393-10)
Initial Posting
06/28/2022
Revised Date

FDA data resources